Free Trial

Onto Innovation (ONTO) Financials

Onto Innovation logo
$203.54 -0.08 (-0.04%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$192.93 -10.61 (-5.21%)
As of 07:54 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Onto Innovation

Annual Income Statements for Onto Innovation

This table shows Onto Innovation's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Income / (Loss) Attributable to Common Shareholders
2.91 44 33 45 1.91 31 142 223 121 202 137
Consolidated Net Income / (Loss)
2.91 44 33 45 1.91 31 142 223 121 202 137
Net Income / (Loss) Continuing Operations
2.91 44 33 45 1.91 31 142 223 121 202 137
Total Pre-Tax Income
5.57 29 60 53 -0.60 -27 156 242 133 220 163
Total Operating Income
4.97 29 59 51 -5.04 -27 156 237 116 187 133
Total Gross Profit
90 114 135 148 135 278 429 539 420 515 500
Total Revenue
187 221 255 274 306 556 789 1,005 816 987 1,005
Operating Revenue
187 221 255 274 306 556 789 1,005 816 987 1,005
Total Cost of Revenue
98 107 121 126 171 278 360 466 396 472 505
Operating Cost of Revenue
98 107 121 126 171 278 360 466 396 472 505
Total Operating Expenses
85 85 75 97 140 252 273 303 304 328 367
Selling, General & Admin Expense
22 23 28 34 53 65 68 70 80 80 107
Marketing Expense
28 30 21 22 28 48 57 66 62 76 70
Research & Development Expense
33 31 38 40 48 85 96 112 104 114 132
Amortization Expense
0.11 0.02 1.94 1.53 10 54 51 55 55 49 39
Other Operating Expenses / (Income)
- - - - - - - - 3.57 9.01 18
Total Other Income / (Expense), net
0.60 0.04 0.51 2.26 4.45 0.19 -0.73 4.87 17 33 30
Interest & Investment Income
0.07 0.04 0.97 2.21 3.67 2.90 1.16 5.01 20 33 35
Other Income / (Expense), net
0.81 0.29 -0.46 0.06 0.78 -2.71 -1.89 -0.14 -3.85 -0.15 -5.00
Income Tax Expense
2.66 -15 27 8.25 -2.51 -4.16 13 18 11 19 26
Basic Earnings per Share
$0.12 $1.79 $1.30 $1.77 $0.06 $0.63 $2.89 $4.52 $2.47 $4.09 $2.78
Weighted Average Basic Shares Outstanding
24.06M 24.66M 25.33M 25.47M 29.73M 49.14M 49.24M 49.42M 48.97M 49.34M 49.12M
Diluted Earnings per Share
$0.12 $1.75 $1.27 $1.74 $0.06 $0.63 $2.86 $4.49 $2.46 $4.06 $2.78
Weighted Average Diluted Shares Outstanding
24.38M 25.15M 25.87M 25.90M 30.01M 49.48M 49.73M 49.76M 49.32M 49.66M 49.27M
Weighted Average Basic & Diluted Shares Outstanding
24.20M 24.60M 25.40M 24.10M 50.28M 48.88M 49.36M 48.75M 49.13M 49.27M 49.70M

Quarterly Income Statements for Onto Innovation

This table shows Onto Innovation's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
47 53 53 49 64 34 28 11 34 60 47
Consolidated Net Income / (Loss)
47 53 53 49 64 34 28 11 34 60 47
Net Income / (Loss) Continuing Operations
47 53 53 49 64 34 28 11 34 60 47
Total Pre-Tax Income
51 57 61 51 72 40 32 20 38 68 65
Total Operating Income
43 49 53 42 63 32 24 14 34 64 95
Total Gross Profit
118 128 136 132 143 122 111 124 146 183 224
Total Revenue
229 242 252 264 267 254 218 267 292 343 410
Operating Revenue
229 242 252 264 267 254 218 267 292 343 410
Total Cost of Revenue
111 114 118 132 123 138 108 133 151 164 185
Operating Cost of Revenue
111 114 118 132 123 138 108 133 151 164 185
Total Operating Expenses
76 79 81 90 80 84 87 120 108 116 129
Selling, General & Admin Expense
18 20 20 26 23 25 25 34 31 34 39
Marketing Expense
18 19 19 19 20 15 17 18 21 23 24
Research & Development Expense
27 27 28 35 28 35 32 36 35 39 45
Amortization Expense
13 13 13 10 8.45 8.45 8.45 14 20 20 20
Restructuring Charge
- - - - - - 4.07 - - - 1.18
Total Other Income / (Expense), net
8.15 8.44 7.94 8.81 8.52 7.49 8.29 5.67 4.54 4.95 -30
Interest & Investment Income
7.36 8.50 8.67 8.97 9.27 8.63 9.29 7.78 5.10 5.25 12
Other Income / (Expense), net
0.79 -0.06 -0.72 -0.15 -0.74 -1.14 -1.00 -2.12 -0.56 -0.30 -42
Income Tax Expense
4.04 4.32 7.96 2.45 7.56 5.83 3.76 9.00 4.30 8.39 18
Basic Earnings per Share
$0.95 $1.07 $1.07 $1.00 $1.30 $0.69 $0.58 $0.21 $0.68 $1.22 $0.96
Weighted Average Basic Shares Outstanding
49.23M 49.34M 49.43M 49.34M 49.18M 48.93M 49.02M 49.12M 49.74M 49.41M 49.05M
Diluted Earnings per Share
$0.94 $1.07 $1.07 $0.98 $1.30 $0.69 $0.57 $0.22 $0.67 $1.21 $0.95
Weighted Average Diluted Shares Outstanding
49.64M 49.67M 49.69M 49.66M 49.41M 49.02M 49.11M 49.27M 50.00M 49.68M 49.26M
Weighted Average Basic & Diluted Shares Outstanding
49.28M 49.38M 49.39M 49.27M 48.87M 49.00M 49.01M 49.70M 49.74M 49.07M 49.08M

Annual Cash Flow Statements for Onto Innovation

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Change in Cash & Equivalents
3.48 8.91 30 45 18 -52 33 24 58 -21 133
Net Cash From Operating Activities
1.57 46 64 35 18 106 175 137 172 246 328
Net Cash From Continuing Operating Activities
1.57 46 64 35 18 50 175 148 172 246 328
Net Income / (Loss) Continuing Operations
2.91 44 33 45 1.91 31 142 223 121 202 137
Consolidated Net Income / (Loss)
2.91 44 33 45 1.91 31 142 223 121 202 137
Depreciation Expense
9.08 8.30 3.99 4.85 5.97 14 14 9.38 12 13 21
Amortization Expense
- - 1.94 1.53 26 64 52 55 50 42 35
Non-Cash Adjustments To Reconcile Net Income
9.02 11 9.87 11 24 37 30 40 39 53 63
Changes in Operating Assets and Liabilities, net
-19 -17 15 -27 -39 -97 -63 -180 -50 -64 73
Net Cash From Investing Activities
1.95 -42 -33 34 4.10 49 -142 -56 -103 -227 -122
Net Cash From Continuing Investing Activities
1.95 -42 -33 34 4.10 -49 -142 -56 -103 -227 -122
Purchase of Property, Plant & Equipment
-1.85 -4.00 -10 -7.54 -6.80 -3.83 -12 -18 -23 -32 -29
Acquisitions
- 0.00 -1.00 - 0.00 0.00 -24 -4.64 0.00 -27 -436
Purchase of Investments
-41 -83 -165 -140 -127 -313 -361 -371 -480 -709 -476
Sale of Property, Plant & Equipment
- 0.00 - - - - 0.00 0.00 2.80 0.00 0.00
Sale and/or Maturity of Investments
45 45 143 186 94 265 255 339 397 541 827
Other Investing Activities, net
- - 0.00 -5.00 0.00 2.85 - - 0.00 0.00 -8.00
Net Cash From Financing Activities
0.22 5.27 -2.55 -24 -4.20 -54 2.67 -68 -9.48 -36 -75
Net Cash From Continuing Financing Activities
0.22 5.27 -2.55 -24 -4.20 -54 2.67 -68 -9.48 -36 -75
Repurchase of Common Equity
-1.72 0.00 -1.03 -21 -0.74 -52 0.00 -65 -3.20 -25 -75
Issuance of Common Equity
3.97 8.45 0.62 0.62 0.84 2.92 10 8.07 5.29 9.18 13
Other Financing Activities, net
-1.18 -2.86 -2.15 -3.46 -4.30 -4.62 -7.40 -11 -12 -20 -14
Effect of Exchange Rate Changes
-0.26 0.08 0.81 -0.34 0.23 - - - - - 1.58
Cash Income Taxes Paid
-0.83 3.77 15 4.30 -3.85 0.00 24 59 34 36 36

Quarterly Cash Flow Statements for Onto Innovation

This table details how cash moves in and out of Onto Innovation's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-43 -18 16 24 -9.22 14 386 -257 -94 1,247 -1,098
Net Cash From Operating Activities
57 65 67 56 92 58 83 95 26 62 79
Net Cash From Continuing Operating Activities
57 65 67 56 92 58 83 95 26 218 -77
Net Income / (Loss) Continuing Operations
47 53 53 49 64 34 28 11 34 60 47
Consolidated Net Income / (Loss)
47 53 53 49 64 34 28 11 34 60 47
Depreciation Expense
3.39 3.53 3.90 2.05 4.40 5.84 4.94 5.86 5.78 5.83 5.83
Amortization Expense
12 13 13 10 6.91 6.95 7.18 14 19 21 14
Non-Cash Adjustments To Reconcile Net Income
7.99 9.85 9.81 25 9.52 27 9.10 18 8.88 11 54
Changes in Operating Assets and Liabilities, net
-13 -14 -13 -30 7.06 -16 34 47 -42 119 -199
Net Cash From Investing Activities
-92 -74 -57 -4.10 -22 -43 297 -353 -113 -230 -932
Net Cash From Continuing Investing Activities
-92 -74 -57 -4.10 -22 -43 297 -353 -113 -230 -932
Purchase of Property, Plant & Equipment
-6.98 -12 -8.05 -4.63 -8.23 -14 -1.38 -5.13 -3.59 -3.66 -1.56
Acquisitions
0.00 - - - -0.06 - - -436 0.00 - 6.50
Purchase of Investments
-208 -187 -143 -171 -209 -211 -1.84 -55 -180 -473 -1,055
Sale and/or Maturity of Investments
123 125 95 198 203 182 300 142 70 246 118
Net Cash From Financing Activities
-5.07 -8.87 3.95 -26 -80 -3.71 5.36 2.71 -6.70 1,170 -0.27
Net Cash From Continuing Financing Activities
-5.07 -8.87 3.95 -26 -80 -3.71 5.36 2.71 -6.70 1,259 -89
Issuance of Debt
- - - - - - - - - - 1.27
Other Financing Activities, net
-9.09 -8.87 -1.22 -0.60 -8.68 -3.71 -0.20 -0.95 -6.70 -12 -90
Cash Income Taxes Paid
0.92 21 8.71 5.27 0.77 32 2.83 0.57 1.57 3.55 1.76

Annual Balance Sheets for Onto Innovation

This table presents Onto Innovation's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/30/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Total Assets
236 288 310 418 1,449 1,468 1,650 1,795 1,910 2,117 2,368
Total Current Assets
178 216 240 351 642 732 948 1,135 1,283 1,478 1,268
Cash & Equivalents
38 47 35 112 131 137 170 176 234 213 346
Short-Term Investments
45 83 82 63 190 237 342 372 464 639 294
Accounts Receivable
38 39 62 64 124 149 177 241 227 308 269
Inventories, net
51 41 54 97 176 191 243 324 328 287 298
Prepaid Expenses
6.59 5.67 6.23 15 22 17 16 21 31 30 61
Plant, Property, & Equipment, net
44 44 45 19 98 88 82 92 104 124 127
Total Noncurrent Assets
13 27 25 48 708 649 620 568 523 516 973
Long-Term Investments
- - - - - - - - - - 0.00
Goodwill
9.42 8.94 10 22 307 307 316 316 316 330 644
Intangible Assets
1.87 0.41 2.21 7.45 372 318 277 222 167 127 298
Noncurrent Deferred & Refundable Income Taxes
1.12 17 12 13 1.46 2.24 4.82 4.78 19 43 3.86
Other Noncurrent Operating Assets
0.53 0.47 0.41 5.51 28 21 22 25 21 15 27
Total Liabilities & Shareholders' Equity
236 288 310 418 1,449 1,468 1,650 1,795 1,910 2,117 2,368
Total Liabilities
48 44 47 56 185 203 224 198 173 191 267
Total Current Liabilities
45 42 44 45 86 120 155 161 148 170 219
Accounts Payable
12 11 14 17 28 40 53 55 50 56 108
Accrued Expenses
- - - 14 26 37 43 49 42 50 49
Current Deferred Revenue
13 9.17 7.41 6.77 13 14 30 30 25 34 32
Other Current Liabilities
8.88 8.05 7.25 7.54 19 28 28 27 31 30 31
Total Noncurrent Liabilities
3.00 2.03 3.22 11 99 83 69 38 25 21 48
Long-Term Debt
- - - - - - - - - - 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
0.52 0.02 0.18 0.00 67 56 40 7.37 0.00 0.00 20
Other Noncurrent Operating Liabilities
0.88 0.35 0.52 11 32 28 29 31 25 21 28
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Total Preferred & Common Equity
187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Total Common Equity
187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Common Stock
259 272 255 370 1,269 1,234 1,256 1,244 1,262 1,275 1,367
Retained Earnings
-66 -22 9.11 -6.77 -4.86 26 169 363 482 665 744
Accumulated Other Comprehensive Income / (Loss)
-5.20 -6.05 -2.12 -1.26 -0.60 4.57 1.32 -10 -7.90 -14 -10

Quarterly Balance Sheets for Onto Innovation

This table presents Onto Innovation's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 7/1/2023 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
1,821 1,862 1,953 2,005 2,073 2,115 2,140 2,187 2,396 3,699 3,803
Total Current Assets
1,183 1,221 1,333 1,385 1,458 1,469 1,494 1,545 1,320 2,642 2,106
Cash & Equivalents
224 207 191 173 189 204 217 603 252 1,253 401
Short-Term Investments
385 423 550 613 667 647 677 381 402 629 851
Accounts Receivable
188 210 232 238 254 292 285 260 307 337 384
Inventories, net
352 346 330 320 308 293 270 259 316 379 424
Prepaid Expenses
34 36 31 42 41 34 44 41 43 43 46
Plant, Property, & Equipment, net
100 104 107 115 120 127 133 129 124 124 121
Total Noncurrent Assets
538 537 514 505 495 519 513 513 953 933 1,575
Long-Term Investments
- - - - - - - - - - 679
Goodwill
316 316 316 316 316 330 330 330 643 643 626
Intangible Assets
195 181 154 141 128 119 111 102 278 259 239
Noncurrent Deferred & Refundable Income Taxes
8.32 18 24 29 35 47 50 57 4.45 4.41 3.32
Other Noncurrent Operating Assets
19 22 19 18 17 23 22 23 27 27 28
Total Liabilities & Shareholders' Equity
1,821 1,862 1,953 2,005 2,073 2,115 2,140 2,187 2,396 3,699 3,803
Total Liabilities
164 166 172 174 170 195 177 185 264 1,776 1,824
Total Current Liabilities
137 136 147 148 145 174 156 163 214 272 311
Accounts Payable
50 44 56 51 48 55 38 53 106 139 140
Accrued Expenses
36 39 35 40 44 42 50 49 46 55 71
Current Deferred Revenue
24 23 26 28 27 39 39 31 31 36 45
Other Current Liabilities
27 29 30 28 26 38 29 30 31 41 55
Total Noncurrent Liabilities
27 30 25 25 25 21 21 22 50 1,505 1,513
Long-Term Debt
- - - - - - - - - 1,472 1,473
Noncurrent Deferred & Payable Income Tax Liabilities
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 20 2.10 5.54
Other Noncurrent Operating Liabilities
27 30 25 25 25 21 21 22 29 31 34
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,657 1,696 1,782 1,832 1,904 1,920 1,963 2,002 2,132 1,923 1,979
Total Preferred & Common Equity
1,657 1,696 1,782 1,832 1,904 1,920 1,963 2,002 2,132 1,923 1,979
Total Common Equity
1,657 1,696 1,782 1,832 1,904 1,920 1,963 2,002 2,132 1,923 1,979
Common Stock
1,251 1,257 1,263 1,263 1,275 1,260 1,263 1,275 1,367 1,098 1,105
Retained Earnings
416 452 529 582 635 671 705 733 778 838 884
Accumulated Other Comprehensive Income / (Loss)
-11 -13 -11 -13 -6.33 -12 -4.75 -6.42 -13 -13 -11

Annual Metrics And Ratios for Onto Innovation

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/26/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/26/2020 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
DEI Shares Outstanding
- - - - - - - - - - 49,011,162.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 49,011,162.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 2.79
Growth Metrics
- - - - - - - - - - -
Revenue Growth
12.57% 18.02% 15.36% 7.33% 11.73% 81.92% 41.76% 27.42% -18.83% 21.01% 1.82%
EBITDA Growth
1,082.87% 153.55% 71.87% -11.18% -52.16% 77.60% 351.62% 36.48% -40.43% 38.92% -24.14%
EBIT Growth
151.30% 407.86% 100.21% -13.07% -108.34% -589.30% 625.84% 53.10% -52.56% 66.59% -31.57%
NOPAT Growth
131.81% 1,594.87% -25.81% 32.36% -108.17% -428.99% 865.84% 53.02% -51.53% 61.36% -34.80%
Net Income Growth
109.34% 1,415.83% -25.27% 37.03% -95.76% 1,524.35% 358.82% 56.89% -45.75% 66.45% -32.19%
EPS Growth
109.23% 1,358.33% -27.43% 37.01% -96.55% 950.00% 353.97% 56.99% -45.21% 65.04% -31.53%
Operating Cash Flow Growth
347.40% 2,808.02% 40.46% -45.31% -48.29% 484.06% 65.38% -22.01% 25.80% 42.86% 33.64%
Free Cash Flow Firm Growth
-156.35% 666.48% -96.85% 58.67% -44,268.62% 104.48% 250.00% -28.85% 36.62% 17.54% -302.35%
Invested Capital Growth
9.07% 9.18% 27.71% 28.52% 405.20% -5.59% 2.66% 14.64% -0.95% 3.35% 36.09%
Revenue Q/Q Growth
1.62% 8.05% 6.48% -15.02% 44.55% 6.62% 9.82% 2.83% -4.05% 4.78% 0.29%
EBITDA Q/Q Growth
33.37% 34.99% 60.93% -39.27% 57.65% -34.65% 67.74% 4.26% -16.41% 4.34% -13.47%
EBIT Q/Q Growth
80.25% 52.85% 77.38% -43.79% -130.08% -117.36% 136.12% 5.96% -24.15% 8.68% -19.28%
NOPAT Q/Q Growth
4,256.71% 180.41% -28.13% -26.55% -125.82% -134.15% 126.37% 7.69% -25.55% 9.74% -23.18%
Net Income Q/Q Growth
3,577.22% 182.86% -28.55% -23.73% -90.02% 567.17% 23.22% 9.55% -22.86% 10.10% -21.87%
EPS Q/Q Growth
0.00% 186.89% -29.83% -26.89% -90.91% 226.00% 22.22% 10.05% -22.88% 10.03% -21.47%
Operating Cash Flow Q/Q Growth
-86.05% 37.09% 137.95% -73.45% 177.50% 60.33% 9.96% 0.36% 7.56% -2.22% 13.48%
Free Cash Flow Firm Q/Q Growth
-347.74% 65.86% -88.43% -97.60% -1,087.42% 104.83% 146.24% -13.84% 25.17% -21.80% -257.42%
Invested Capital Q/Q Growth
1.04% 16.00% 8.37% 54.22% 374.61% -0.70% 0.30% 3.15% -2.60% 2.43% 43.50%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
47.86% 51.61% 52.76% 54.16% 44.14% 50.04% 54.39% 53.64% 51.51% 52.19% 49.72%
EBITDA Margin
7.93% 17.04% 25.39% 21.01% 9.00% 8.78% 27.98% 29.97% 21.99% 25.25% 18.27%
Operating Margin
2.65% 13.16% 23.24% 18.66% -1.65% -4.79% 19.83% 23.55% 14.23% 18.95% 13.22%
EBIT Margin
3.09% 13.29% 23.06% 18.68% -1.39% -5.28% 19.59% 23.54% 13.76% 18.94% 12.73%
Profit (Net Income) Margin
1.55% 19.91% 12.90% 16.47% 0.62% 5.58% 18.04% 22.22% 14.85% 20.43% 13.60%
Tax Burden Percent
52.17% 151.14% 55.03% 84.53% -319.93% -115.47% 91.44% 92.45% 91.38% 91.48% 83.95%
Interest Burden Percent
96.23% 99.15% 101.65% 104.31% 14.00% 91.43% 100.75% 102.12% 118.14% 117.91% 127.34%
Effective Tax Rate
47.83% -51.14% 44.97% 15.47% 0.00% 0.00% 8.56% 7.55% 8.62% 8.52% 16.05%
Return on Invested Capital (ROIC)
2.60% 40.33% 25.18% 26.00% -0.62% -2.04% 15.84% 22.29% 10.16% 16.21% 8.81%
ROIC Less NNEP Spread (ROIC-NNEP)
2.23% 40.28% 24.95% 24.69% -2.82% -16.36% 15.99% 21.44% 7.74% 12.27% 5.43%
Return on Net Nonoperating Assets (RNNOA)
-1.01% -19.90% -12.17% -11.55% 0.86% 4.49% -5.26% -7.51% -2.89% -5.19% -2.01%
Return on Equity (ROE)
1.58% 20.43% 13.00% 14.45% 0.23% 2.45% 10.58% 14.78% 7.27% 11.01% 6.79%
Cash Return on Invested Capital (CROIC)
-6.08% 31.56% 0.84% 1.04% -134.53% 3.72% 13.22% 8.65% 11.11% 12.91% -21.77%
Operating Return on Assets (OROA)
2.52% 11.23% 19.69% 14.05% -0.46% -2.01% 9.91% 13.74% 6.06% 9.29% 5.71%
Return on Assets (ROA)
1.27% 16.83% 11.02% 12.39% 0.20% 2.13% 9.13% 12.97% 6.54% 10.02% 6.10%
Return on Common Equity (ROCE)
1.58% 20.43% 13.00% 14.45% 0.23% 2.45% 10.58% 14.78% 7.27% 11.01% 6.79%
Return on Equity Simple (ROE_SIMPLE)
1.55% 18.06% 12.54% 12.46% 0.15% 2.45% 9.98% 13.99% 6.98% 10.47% 0.00%
Net Operating Profit after Tax (NOPAT)
2.59 44 33 43 -3.53 -19 143 219 106 171 112
NOPAT Margin
1.38% 19.89% 12.79% 15.77% -1.15% -3.36% 18.13% 21.77% 13.00% 17.34% 11.10%
Net Nonoperating Expense Percent (NNEP)
0.37% 0.06% 0.23% 1.31% 2.20% 14.32% -0.15% 0.85% 2.42% 3.94% 3.37%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 13.71% 6.11% 8.89% 5.31%
Cost of Revenue to Revenue
52.14% 48.39% 47.24% 45.84% 55.86% 49.96% 45.61% 46.36% 48.49% 47.81% 50.28%
SG&A Expenses to Revenue
11.98% 10.57% 10.93% 12.31% 17.33% 11.74% 8.61% 6.92% 10.19% 8.69% 10.65%
R&D to Revenue
17.45% 14.22% 14.78% 14.59% 15.81% 15.20% 12.18% 11.14% 12.80% 11.83% 13.13%
Operating Expenses to Revenue
45.20% 38.45% 29.52% 35.50% 45.79% 45.24% 34.56% 30.09% 37.28% 33.24% 36.49%
Earnings before Interest and Taxes (EBIT)
5.79 29 59 51 -4.26 -29 155 237 112 187 128
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
15 38 65 58 28 49 221 301 179 249 184
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.04 2.56 2.43 1.83 1.45 1.85 3.50 2.11 4.32 4.38 3.87
Price to Tangible Book Value (P/TBV)
2.17 2.66 2.55 1.99 3.13 3.67 5.99 3.19 5.99 5.74 7.02
Price to Revenue (P/Rev)
2.04 2.82 2.50 2.42 5.98 4.21 6.32 3.35 9.20 8.54 8.09
Price to Earnings (P/E)
131.47 14.18 19.38 14.68 957.73 75.58 35.04 15.10 61.94 41.80 59.44
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.76% 7.05% 5.16% 6.81% 0.10% 1.32% 2.85% 6.62% 1.61% 2.39% 1.68%
Enterprise Value to Invested Capital (EV/IC)
2.87 4.34 3.58 2.61 1.60 2.21 4.89 2.69 6.55 7.06 5.13
Enterprise Value to Revenue (EV/Rev)
1.60 2.24 2.04 1.78 4.93 3.54 5.68 2.81 8.34 7.67 7.45
Enterprise Value to EBITDA (EV/EBITDA)
20.11 13.12 8.04 8.46 54.84 40.33 20.28 9.37 37.93 30.40 40.79
Enterprise Value to EBIT (EV/EBIT)
51.65 16.83 8.85 9.52 0.00 0.00 28.97 11.94 60.65 40.53 58.55
Enterprise Value to NOPAT (EV/NOPAT)
115.18 11.24 15.96 11.27 0.00 0.00 31.31 12.90 64.17 44.27 67.12
Enterprise Value to Operating Cash Flow (EV/OCF)
190.23 10.82 8.12 13.87 83.16 18.60 25.54 20.66 39.58 30.84 22.81
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 14.37 479.93 282.69 0.00 57.82 37.52 33.26 58.68 55.57 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.46 -0.49 -0.49 -0.47 -0.30 -0.27 -0.33 -0.35 -0.37 -0.42 -0.37
Leverage Ratio
1.25 1.21 1.18 1.17 1.15 1.15 1.16 1.14 1.11 1.10 1.11
Compound Leverage Factor
1.20 1.20 1.20 1.22 0.16 1.05 1.17 1.16 1.31 1.30 1.42
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
5.91 10.23 10.34 8.99 6.60 7.75 14.88 12.12 27.69 28.39 19.84
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.94 5.15 5.45 7.80 7.48 6.09 6.14 7.07 8.69 8.69 5.79
Quick Ratio
2.67 4.03 4.07 5.32 5.18 4.35 4.46 4.92 6.26 6.82 4.15
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-6.07 34 1.09 1.72 -761 34 119 85 116 136 -276
Operating Cash Flow to CapEx
85.10% 1,142.41% 628.51% 465.31% 266.77% 2,767.93% 1,455.94% 742.75% 869.74% 770.07% 1,151.46%
Free Cash Flow to Firm to Interest Expense
-21.02 120.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
5.44 160.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-0.95 146.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.82 0.85 0.85 0.75 0.33 0.38 0.51 0.58 0.44 0.49 0.45
Accounts Receivable Turnover
5.86 5.72 5.01 4.32 3.26 4.08 4.83 4.80 3.49 3.69 3.48
Inventory Turnover
2.23 2.33 2.52 1.66 1.25 1.51 1.66 1.64 1.21 1.54 1.73
Fixed Asset Turnover
3.98 4.98 5.73 8.60 5.22 5.97 9.28 11.55 8.34 8.68 8.01
Accounts Payable Turnover
8.93 9.30 9.56 8.14 7.64 8.19 7.69 8.64 7.58 8.90 6.17
Days Sales Outstanding (DSO)
62.29 63.79 72.91 84.42 112.07 89.50 75.52 76.00 104.68 98.84 104.76
Days Inventory Outstanding (DIO)
163.67 156.74 144.92 219.88 291.54 241.12 220.29 222.23 300.80 237.69 211.29
Days Payable Outstanding (DPO)
40.86 39.26 38.16 44.84 47.76 44.58 47.44 42.25 48.16 41.03 59.19
Cash Conversion Cycle (CCC)
185.11 181.27 179.67 259.47 355.85 286.04 248.38 255.98 357.32 295.49 256.87
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
104 114 145 187 944 891 915 1,049 1,039 1,074 1,461
Invested Capital Turnover
1.88 2.03 1.97 1.65 0.54 0.61 0.87 1.02 0.78 0.93 0.79
Increase / (Decrease) in Invested Capital
8.67 9.57 32 41 757 -53 24 134 -9.92 35 387
Enterprise Value (EV)
299 494 521 487 1,509 1,971 4,477 2,824 6,807 7,577 7,490
Market Capitalization
382 624 638 662 1,829 2,345 4,988 3,372 7,504 8,429 8,129
Book Value per Share
$7.74 $9.78 $10.25 $14.94 $25.25 $25.90 $28.94 $32.24 $35.38 $38.99 $42.86
Tangible Book Value per Share
$7.28 $9.41 $9.77 $13.71 $11.68 $13.10 $16.90 $21.37 $25.54 $29.73 $23.64
Total Capital
187 244 262 362 1,264 1,265 1,426 1,596 1,737 1,926 2,101
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-83 -130 -117 -175 -320 -374 -511 -548 -698 -852 -640
Capital Expenditures (CapEx)
1.85 4.00 10 7.54 6.80 3.83 12 18 20 32 29
Debt-free, Cash-free Net Working Capital (DFCFNWC)
50 44 79 131 236 238 282 427 438 455 409
Debt-free Net Working Capital (DFNWC)
133 174 196 306 556 612 794 974 1,136 1,307 1,049
Net Working Capital (NWC)
133 174 196 306 556 612 794 974 1,136 1,307 1,049
Net Nonoperating Expense (NNE)
-0.31 -0.06 -0.28 -1.91 -5.44 -50 0.66 -4.50 -15 -31 -25
Net Nonoperating Obligations (NNO)
-83 -130 -117 -175 -320 -374 -511 -548 -698 -852 -640
Total Depreciation and Amortization (D&A)
9.08 8.30 5.93 6.38 32 78 66 65 67 62 56
Debt-free, Cash-free Net Working Capital to Revenue
26.59% 20.08% 30.96% 47.79% 77.05% 42.74% 35.77% 42.43% 53.65% 46.09% 40.73%
Debt-free Net Working Capital to Revenue
70.93% 78.85% 76.84% 111.74% 181.74% 109.90% 100.59% 96.93% 139.18% 132.42% 104.36%
Net Working Capital to Revenue
70.93% 78.85% 76.84% 111.74% 181.74% 109.90% 100.59% 96.93% 139.18% 132.42% 104.36%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.12 $1.79 $1.19 $2.39 $0.06 $0.63 $2.89 $0.00 $2.47 $4.09 $2.78
Adjusted Weighted Average Basic Shares Outstanding
24.06M 24.66M 25.33M 24.12M 29.73M 49.14M 49.24M 0.00 48.97M 49.34M 49.12M
Adjusted Diluted Earnings per Share
$0.12 $1.75 $1.17 $2.34 $0.06 $0.63 $2.86 $0.00 $2.46 $4.06 $2.78
Adjusted Weighted Average Diluted Shares Outstanding
24.38M 25.15M 25.92M 24.60M 30.01M 49.48M 49.73M 0.00 49.32M 49.66M 49.27M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
24.30M 25.16M 23.76M 24.46M 50.28M 48.88M 49.36M 0.00 49.13M 49.27M 49.70M
Normalized Net Operating Profit after Tax (NOPAT)
3.31 20 25 43 -3.53 -19 143 219 106 171 112
Normalized NOPAT Margin
1.77% 9.21% 9.99% 15.77% -1.15% -3.36% 18.13% 21.77% 13.00% 17.34% 11.10%
Pre Tax Income Margin
2.97% 13.18% 23.44% 19.48% -0.20% -4.83% 19.73% 24.03% 16.25% 22.33% 16.20%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
20.02 103.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
8.98 154.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
13.63 89.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
2.59 140.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
29.29% 0.72% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
88.54% 0.72% 3.11% 46.72% 38.95% 167.61% 0.00% 29.22% 2.64% 12.43% 54.85%

Quarterly Metrics And Ratios for Onto Innovation

This table displays calculated financial ratios and metrics derived from Onto Innovation's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - 49,011,162.00 49,702,361.00 49,743,567.00 49,074,247.00
DEI Adjusted Shares Outstanding
- - - - - - - 49,011,162.00 49,702,361.00 49,743,567.00 49,074,247.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - 0.21 0.68 1.21 0.95
Growth Metrics
- - - - - - - - - - -
Revenue Growth
14.90% 27.10% 21.73% 20.60% 16.50% 4.65% -13.49% 1.11% 9.51% 35.30% 87.79%
EBITDA Growth
31.95% 64.28% 38.63% 23.52% 26.09% -30.94% -48.38% -40.64% -21.02% 80.55% 154.72%
EBIT Growth
51.39% 111.17% 58.61% 54.57% 43.33% -36.21% -56.66% -72.25% -47.19% 103.31% 134.99%
NOPAT Growth
50.12% 95.77% 46.33% 59.83% 43.52% -39.05% -54.69% -81.52% -47.36% 102.65% 229.11%
Net Income Growth
61.18% 104.47% 47.83% 61.06% 36.80% -35.96% -46.80% -78.43% -47.34% 77.23% 65.98%
EPS Growth
59.32% 101.89% 46.58% 60.66% 38.30% -35.51% -46.73% -77.55% -48.46% 75.36% 66.67%
Operating Cash Flow Growth
14.11% 106.07% 134.87% -9.07% 61.00% -11.27% 24.01% 69.64% -71.38% 6.15% -5.57%
Free Cash Flow Firm Growth
147.15% 213.41% 452.82% -84.10% -29.50% -89.64% -21.10% -6,888.44% -1,450.72% -8,135.55% -955.50%
Invested Capital Growth
-0.05% -0.14% -1.72% 3.35% 2.73% 2.17% -2.86% 36.09% 38.26% 41.55% 49.52%
Revenue Q/Q Growth
4.56% 5.89% 4.08% 4.65% 1.01% -4.88% -13.96% 22.31% 0.00% 17.53% 19.42%
EBITDA Q/Q Growth
36.15% 8.97% 6.02% -21.48% 35.32% -40.42% -20.72% -10.29% 0.00% 55.00% -18.82%
EBIT Q/Q Growth
59.05% 12.04% 7.33% -19.18% 47.48% -50.14% -27.07% -48.25% 0.00% 91.96% -15.71%
NOPAT Q/Q Growth
55.55% 14.75% 2.20% -12.39% 39.68% -51.27% -24.02% -64.26% 0.00% 87.59% 23.39%
Net Income Q/Q Growth
54.58% 13.01% 0.19% -7.98% 31.30% -47.09% -16.77% -62.69% 0.00% 78.08% -22.06%
EPS Q/Q Growth
54.10% 13.83% 0.00% -8.41% 32.65% -46.92% -17.39% -61.40% 0.00% 80.60% -21.49%
Operating Cash Flow Q/Q Growth
-7.23% 14.30% 2.98% -16.73% 64.25% -37.00% 43.93% 13.91% 0.00% 133.67% 28.03%
Free Cash Flow Firm Q/Q Growth
13.12% 17.03% 38.37% -91.32% 401.64% -82.80% 953.53% -846.71% 0.00% -2.34% -12.16%
Invested Capital Q/Q Growth
0.18% 0.48% 0.24% 2.43% -0.42% -0.06% -4.70% 43.50% 0.00% 2.31% 0.67%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
51.69% 52.92% 54.07% 50.17% 53.72% 48.16% 50.70% 46.39% 50.14% 53.41% 54.79%
EBITDA Margin
26.23% 27.00% 27.50% 20.63% 27.64% 17.31% 15.95% 11.70% 19.94% 26.29% 17.87%
Operating Margin
18.68% 20.15% 21.04% 16.09% 23.68% 12.72% 10.86% 5.19% 11.48% 18.52% 23.29%
EBIT Margin
19.02% 20.13% 20.76% 16.03% 23.40% 12.27% 10.40% 4.40% 11.29% 18.43% 13.01%
Profit (Net Income) Margin
20.47% 21.85% 21.03% 18.50% 24.04% 13.37% 12.94% 3.95% 11.56% 17.52% 11.43%
Tax Burden Percent
92.06% 92.46% 86.95% 95.21% 89.45% 85.33% 88.26% 53.93% 88.69% 87.75% 72.09%
Interest Burden Percent
116.91% 117.42% 116.56% 121.19% 114.85% 127.74% 140.95% 166.30% 115.48% 108.29% 121.89%
Effective Tax Rate
7.94% 7.54% 13.05% 4.79% 10.55% 14.67% 11.74% 46.07% 11.31% 12.25% 27.91%
Return on Invested Capital (ROIC)
13.97% 15.98% 16.31% 14.32% 20.58% 10.64% 9.30% 2.22% 0.00% 0.00% 17.34%
ROIC Less NNEP Spread (ROIC-NNEP)
12.83% 14.86% 15.38% 13.24% 19.63% 9.88% 8.50% 1.81% 0.00% 0.00% 20.39%
Return on Net Nonoperating Assets (RNNOA)
-4.99% -5.94% -6.34% -5.60% -8.44% -4.38% -4.00% -0.67% 0.00% 0.00% -7.38%
Return on Equity (ROE)
8.98% 10.03% 9.96% 8.72% 12.14% 6.26% 5.29% 1.55% 0.00% 0.00% 9.96%
Cash Return on Invested Capital (CROIC)
11.50% 13.64% 16.49% 12.91% 15.16% 13.99% 16.96% -21.77% -32.12% -34.40% -26.83%
Operating Return on Assets (OROA)
8.56% 9.44% 9.94% 7.86% 11.79% 6.13% 4.89% 1.97% 0.00% 0.00% 5.70%
Return on Assets (ROA)
9.22% 10.25% 10.07% 9.07% 12.11% 6.69% 6.09% 1.77% 0.00% 0.00% 5.01%
Return on Common Equity (ROCE)
8.98% 10.03% 9.96% 8.72% 12.14% 6.26% 5.29% 1.55% 0.00% 0.00% 9.96%
Return on Equity Simple (ROE_SIMPLE)
7.80% 9.06% 9.62% 0.00% 11.40% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
39 45 46 40 56 28 21 7.47 30 56 69
NOPAT Margin
17.19% 18.63% 18.30% 15.32% 21.18% 10.85% 9.58% 2.80% 10.18% 16.25% 16.79%
Net Nonoperating Expense Percent (NNEP)
1.13% 1.12% 0.93% 1.08% 0.96% 0.76% 0.80% 0.41% 0.54% 0.66% -3.05%
Return On Investment Capital (ROIC_SIMPLE)
- - - 2.10% 2.94% 1.40% 1.04% 0.36% 1.39% 1.64% 1.99%
Cost of Revenue to Revenue
48.31% 47.08% 45.93% 49.83% 46.28% 54.30% 51.17% 49.75% 51.64% 47.69% 45.21%
SG&A Expenses to Revenue
7.67% 8.37% 8.91% 9.68% 8.97% 9.86% 11.38% 12.92% 10.76% 9.98% 9.57%
R&D to Revenue
11.60% 11.16% 11.21% 13.22% 10.51% 13.92% 14.89% 13.55% 12.02% 11.33% 11.00%
Operating Expenses to Revenue
33.01% 32.77% 33.03% 34.08% 30.04% 32.99% 37.98% 45.05% 36.88% 33.79% 31.49%
Earnings before Interest and Taxes (EBIT)
44 49 52 42 62 31 23 12 33 63 53
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
60 65 69 54 74 44 35 31 58 90 73
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.99 5.91 5.59 4.38 3.13 2.46 3.12 3.87 4.78 9.79 7.63
Price to Tangible Book Value (P/TBV)
6.78 7.87 7.29 5.74 4.09 3.17 3.98 7.02 8.42 18.45 13.55
Price to Revenue (P/Rev)
10.51 12.06 11.29 8.54 5.87 4.66 6.24 8.09 0.00 0.00 11.52
Price to Earnings (P/E)
63.97 65.18 58.07 41.80 27.47 24.18 35.72 59.44 0.00 0.00 99.89
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
1.56% 1.53% 1.72% 2.39% 3.64% 4.14% 2.80% 1.68% 0.00% 0.00% 1.00%
Enterprise Value to Invested Capital (EV/IC)
7.83 9.60 9.33 7.06 4.83 3.69 5.17 5.13 6.45 12.18 9.62
Enterprise Value to Revenue (EV/Rev)
9.63 11.18 10.38 7.67 5.04 3.80 5.26 7.45 0.00 0.00 11.17
Enterprise Value to EBITDA (EV/EBITDA)
42.00 45.69 40.94 30.40 19.52 16.08 24.82 40.79 0.00 0.00 57.93
Enterprise Value to EBIT (EV/EBIT)
64.15 65.71 56.86 40.53 25.09 20.93 33.24 58.55 0.00 0.00 90.84
Enterprise Value to NOPAT (EV/NOPAT)
68.34 71.00 62.70 44.27 27.42 23.08 36.26 67.12 0.00 0.00 89.68
Enterprise Value to Operating Cash Flow (EV/OCF)
45.50 47.18 38.92 30.84 18.41 14.42 18.21 22.81 0.00 0.00 56.00
Enterprise Value to Free Cash Flow (EV/FCFF)
68.06 70.27 56.10 55.57 32.29 26.62 30.06 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.77 0.74
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.77 0.74
Financial Leverage
-0.39 -0.40 -0.41 -0.42 -0.43 -0.44 -0.47 -0.37 -0.37 -0.34 -0.36
Leverage Ratio
1.10 1.10 1.09 1.10 1.10 1.09 1.09 1.11 1.11 1.50 1.50
Compound Leverage Factor
1.29 1.29 1.27 1.33 1.26 1.40 1.54 1.85 1.29 1.63 1.83
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 43.36% 42.67%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 43.36% 42.67%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 56.64% 57.33%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.83
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.81
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.83
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.02
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.80
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.02
Altman Z-Score
32.65 39.04 39.30 28.16 20.23 18.13 22.05 19.67 24.20 7.50 6.25
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
9.06 9.33 10.07 8.69 8.42 9.59 9.49 5.79 6.15 9.73 6.78
Quick Ratio
6.62 6.90 7.66 6.82 6.55 7.58 7.64 4.15 4.48 8.17 5.26
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
40 47 65 5.60 28 4.83 51 -380 -379 -388 -435
Operating Cash Flow to CapEx
819.08% 532.92% 835.47% 1,210.53% 1,117.21% 420.73% 6,047.57% 1,852.13% 734.23% 1,681.90% 5,044.84%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.45 0.47 0.48 0.49 0.50 0.50 0.47 0.45 0.00 0.00 0.44
Accounts Receivable Turnover
3.83 4.22 4.07 3.69 3.92 3.96 3.90 3.48 0.00 0.00 4.07
Inventory Turnover
1.23 1.30 1.38 1.54 1.56 1.72 1.77 1.73 0.00 0.00 1.86
Fixed Asset Turnover
8.27 8.33 8.40 8.68 8.76 8.34 8.05 8.01 0.00 0.00 10.47
Accounts Payable Turnover
7.52 8.63 9.76 8.90 8.71 11.40 9.95 6.17 0.00 0.00 6.60
Days Sales Outstanding (DSO)
95.29 86.59 89.72 98.84 93.19 92.13 93.57 104.76 0.00 0.00 89.70
Days Inventory Outstanding (DIO)
295.85 281.28 264.57 237.69 234.20 211.75 206.34 211.29 0.00 0.00 195.98
Days Payable Outstanding (DPO)
48.55 42.28 37.38 41.03 41.89 32.03 36.68 59.19 0.00 0.00 55.32
Cash Conversion Cycle (CCC)
342.59 325.58 316.91 295.49 285.51 271.85 263.23 256.87 0.00 0.00 230.36
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,041 1,046 1,048 1,074 1,069 1,068 1,018 1,461 1,478 1,512 1,522
Invested Capital Turnover
0.81 0.86 0.89 0.93 0.97 0.98 0.97 0.79 0.00 0.00 1.03
Increase / (Decrease) in Invested Capital
-0.49 -1.47 -18 35 28 23 -30 387 409 444 504
Enterprise Value (EV)
8,147 10,033 9,780 7,577 5,164 3,938 5,268 7,490 9,538 18,415 14,649
Market Capitalization
8,888 10,819 10,636 8,429 6,014 4,833 6,252 8,129 10,192 18,825 15,106
Book Value per Share
$36.19 $37.17 $38.55 $38.99 $38.96 $40.17 $40.86 $42.86 $42.90 $38.65 $40.33
Tangible Book Value per Share
$26.64 $27.90 $29.56 $29.73 $29.85 $31.15 $32.04 $23.64 $24.35 $20.52 $22.71
Total Capital
1,782 1,832 1,904 1,926 1,920 1,963 2,002 2,101 2,132 3,394 3,452
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,472 1,473
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,472 1,473
Net Debt
-741 -786 -855 -852 -851 -895 -984 -640 -654 -410 -457
Capital Expenditures (CapEx)
6.98 12 8.05 4.63 8.23 14 1.38 5.13 3.59 3.66 1.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)
445 451 458 455 444 444 398 409 451 488 544
Debt-free Net Working Capital (DFNWC)
1,186 1,237 1,313 1,307 1,295 1,339 1,382 1,049 1,105 2,370 1,795
Net Working Capital (NWC)
1,186 1,237 1,313 1,307 1,295 1,339 1,382 1,049 1,105 2,370 1,795
Net Nonoperating Expense (NNE)
-7.51 -7.80 -6.91 -8.39 -7.62 -6.39 -7.32 -3.06 -4.02 -4.34 22
Net Nonoperating Obligations (NNO)
-741 -786 -855 -852 -851 -895 -984 -640 -654 -410 -457
Total Depreciation and Amortization (D&A)
17 17 17 12 11 13 12 19 25 27 20
Debt-free, Cash-free Net Working Capital to Revenue
52.61% 50.24% 48.59% 46.09% 43.33% 42.81% 39.72% 40.73% 0.00% 0.00% 41.47%
Debt-free Net Working Capital to Revenue
140.24% 137.85% 139.37% 132.42% 126.31% 129.17% 137.88% 104.36% 0.00% 0.00% 136.88%
Net Working Capital to Revenue
140.24% 137.85% 139.37% 132.42% 126.31% 129.17% 137.88% 104.36% 0.00% 0.00% 136.88%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.95 $1.07 $1.07 $1.00 $1.30 $0.69 $0.58 $0.21 $0.68 $1.22 $0.96
Adjusted Weighted Average Basic Shares Outstanding
49.23M 49.34M 49.43M 49.34M 49.18M 48.93M 49.02M 49.12M 49.74M 49.41M 49.05M
Adjusted Diluted Earnings per Share
$0.94 $1.07 $1.07 $0.98 $1.30 $0.69 $0.57 $0.22 $0.67 $1.21 $0.95
Adjusted Weighted Average Diluted Shares Outstanding
49.64M 49.67M 49.69M 49.66M 49.41M 49.02M 49.11M 49.27M 50.00M 49.68M 49.26M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
49.28M 49.38M 49.39M 49.27M 48.87M 49.00M 49.01M 49.70M 49.74M 49.07M 49.08M
Normalized Net Operating Profit after Tax (NOPAT)
39 45 46 40 56 28 21 7.47 30 56 70
Normalized NOPAT Margin
17.19% 18.63% 18.30% 15.32% 21.18% 10.85% 9.58% 2.80% 10.18% 16.25% 17.00%
Pre Tax Income Margin
22.24% 23.63% 24.19% 19.43% 26.88% 15.67% 14.66% 7.32% 13.03% 19.96% 15.86%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 12.43% 45.72% 50.07% 57.18% 54.85% 0.00% 0.00% 135.54%

Financials Breakdown Chart

Key Financial Trends

Onto Innovation’s latest results show a sharp acceleration in revenue and profitability, although the balance sheet now reflects materially higher debt and the cash-flow data contains an apparent classification inconsistency. Revenue increased from $190.7 million in Q2 2023 to $343.1 million in Q2 2026, an approximately 80% rise. Q2 2026 revenue also grew 35% year over year and 18% sequentially from Q1 2026.

Profitability has improved meaningfully from the Q4 2025 trough. Q2 2026 gross profit was $183.3 million, producing a 53.4% gross margin compared with 48.2% in Q2 2025. Operating income rose to $63.6 million from $33.5 million in Q1 2026, while net income reached $60.1 million, or $1.21 per diluted share. That compares with $33.8 million of net income and $0.67 of diluted EPS in the prior quarter.

The longer-term earnings trend is positive but uneven. Net income increased from $30.3 million in Q4 2023 to $48.8 million in Q4 2024, fell to $10.5 million in Q4 2025, and then recovered to $60.1 million in Q2 2026. Investors should distinguish the strong current rebound from a consistently stable earnings trajectory.

  • Revenue growth has accelerated: Q2 2026 revenue of $343.1 million was up 35% year over year and approximately 80% above Q2 2023.
  • Margins recovered: Gross margin improved to 53.4% in Q2 2026 from 48.2% in Q2 2025, while operating margin increased to approximately 18.5% from 13.2%.
  • EPS momentum is strong: Diluted EPS rose to $1.21 in Q2 2026 from $0.67 in Q1 and $0.69 in Q2 2025.
  • Operating cash flow remains positive: Reported cash flow from operating activities was $61.5 million in Q2 2026, following $26.3 million in Q1 and $57.9 million in Q2 2025.
  • Liquidity is substantial: Cash and short-term investments totaled approximately $1.88 billion at the end of Q2 2026, providing flexibility for investment, acquisitions, or shareholder returns.
  • Current liquidity remains strong: Current assets of $2.64 billion substantially exceeded current liabilities of $271.6 million, implying a current ratio of nearly 10 times.
  • Share repurchases may support per-share results: Onto Innovation repurchased approximately $205.0 million of common stock in Q2 2026, which can enhance EPS if operating performance remains strong.
  • Cash deployment is heavily concentrated in investments: The company purchased $472.6 million of investments and sold or received maturities of $246.1 million in Q2 2026. This appears primarily to be treasury portfolio management rather than core capital investment.
  • Debt increased sharply: Q2 2026 long-term debt was reported at $1.47 billion, compared with no long-term debt shown in the earlier balance sheets provided. Total liabilities rose to $1.78 billion from $264.2 million in Q1 2026.
  • Cash-flow classifications require caution: The Q2 2026 statement reports $1.17 billion of net financing cash inflow and $1.25 billion of net change in cash, but the listed financing components do not appear to reconcile to that total. Investors should verify the company’s filing before relying on the reported cash increase.

Overall, the income statement points to strong operating momentum, with revenue, margins, net income, and EPS all improving substantially in the latest quarter. The main risks are the newly reported debt burden, the sustainability of the rebound after a weak Q4 2025, and the need to clarify the Q2 2026 cash-flow presentation.

11/16/26 07:54 AM ETAI Generated. May Contain Errors.

Onto Innovation Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Onto Innovation's fiscal year ends in January. Their fiscal year 2026 ended on January 3, 2026.

Onto Innovation's net income appears to be on an upward trend, with a most recent value of $136.76 million in 2025, rising from $2.91 million in 2015. The previous period was $201.67 million in 2024. See where experts think Onto Innovation is headed by visiting Onto Innovation's forecast page.

Onto Innovation's total operating income in 2025 was $132.93 million, based on the following breakdown:
  • Total Gross Profit: $499.77 million
  • Total Operating Expenses: $366.84 million

Over the last 10 years, Onto Innovation's total revenue changed from $187.37 million in 2015 to $1.01 billion in 2025, a change of 436.5%.

In the past 13 quarters, Onto Innovation's cash and equivalents has ranged from $172.57 million in Q2 2024 to $1.25 billion in Q2 2026, and is currently $400.68 million as of their latest financial filing in Q3 2026.

Onto Innovation had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2015.

Over the last 10 years, Onto Innovation's book value per share changed from 7.74 in 2015 to 42.86 in 2025, a change of 453.4%.



Financial statements for NYSE:ONTO last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners